Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Total Liabilities (2018 - 2025)

Dna X (SONM) has disclosed Total Liabilities for 8 consecutive years, with $40.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Liabilities rose 21.07% year-over-year to $40.9 million, compared with a TTM value of $40.9 million through Sep 2025, up 21.07%, and an annual FY2024 reading of $45.4 million, up 34.93% over the prior year.
  • Total Liabilities was $40.9 million for Q3 2025 at Dna X, up from $37.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $45.4 million in Q4 2024 and bottomed at $21.3 million in Q1 2021.
  • Average Total Liabilities over 5 years is $31.2 million, with a median of $31.1 million recorded in 2023.
  • The sharpest move saw Total Liabilities decreased 28.99% in 2021, then soared 64.27% in 2025.
  • Year by year, Total Liabilities stood at $22.5 million in 2021, then skyrocketed by 49.78% to $33.6 million in 2022, then rose by 0.1% to $33.7 million in 2023, then skyrocketed by 34.93% to $45.4 million in 2024, then fell by 9.95% to $40.9 million in 2025.
  • Business Quant data shows Total Liabilities for SONM at $40.9 million in Q3 2025, $37.4 million in Q2 2025, and $37.0 million in Q1 2025.